Imprimis NJOF, LLC recalls
4 notices naming Imprimis NJOF, LLC as the recalling firm, since April 9, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Imprimis NJOF, LLC: Dexamethasone Moxifloxacin and 2 more
Hazard (FDA): Presence of particulate matter - Glass like particles.
FDAMedicines
Imprimis NJOF, LLC: Epinephrine Lidocaine HCL and 1 more
Hazard (FDA): Sub-Potent Drug: Subpotent assay results during stability testing.
FDAMedicines
Imprimis NJOF, LLC: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution
Hazard (FDA): Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
FDAMedicines